Give us a call 215-275-1556

Open Payments 2.0 – Big Changes Are Forecast

The forecast for transparency just turned cloudy. Key Messages  Tucked into the latest opioid law are changes to the Sunshine Act.Beginning in 2022, drug and device companies now must report transfers of value to advance practice nurses and physician assistants.CMS...

A Cloudy Future for the Sunshine Act

The due date for posting another year’s worth of Physician Payment  Sunshine Act (a.k.a. Open Payments) data is fast approaching.  But the future for the Sunshine Act is cloudy.  A new Republican President combined with a recent academic study cast doubt on the...

Transparency’s Uncertain Future

I just returned from speaking at CBI’s 10th Annual Forum on Transparency and Aggregate Spend.  After 10 years and 3 CMS Open Payments reporting cycles, I’m struck by how uncertain the once bright future of the Sunshine Act is.  Overall, the industry...

Enforcing Sunshine

As noted in a recent article from Policy and Medicine, we have now received our first definitive indication that the OIG and CMS are moving to enforce the Sunshine Act reporting requirements.  According to Mary Riordan, senior counsel at the Health and Human...

Sunshine hits the UK National Health Service

As we’ve been noting for some time now, transparency efforts in the life sciences industry are here to stay.   Within the last 48 hours, the UK has stepped up the game by announcing new rules for National Health Service (NHS) hospitals and General Practitioner...